How is risk classified in rhabdomyosarcoma?

Updated: Feb 01, 2019
  • Author: Amelia F Drake, MD; Chief Editor: Arlen D Meyers, MD, MBA  more...
  • Print
Answer

Answer

See the list below:

  • Low risk: Patients have embryonal rhabdomyosarcoma at a favorable site (stage I), at an unfavorable site with complete resection (group I), or at an unfavorable site with microscopic residual disease (group II).

  • Intermediate risk: Patients have embryonal rhabdomyosarcoma at an unfavorable site with gross residual disease (group III), metastatic embryonal rhabdomyosarcoma and are younger than 10 years, or any nonmetastatic alveolar rhabdomyosarcoma at any site.

  • High risk: Those at high risk include any patient with metastatic disease unless he or she is younger than 10 years and has embryonal metastasis.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!